Targeting Inhibition of SmpB by Peptide Aptamer Attenuates the Virulence to Protect Zebrafish against Aeromonas veronii Infection

is an important pathogen of aquatic animals, wherein Small protein B (SmpB) is required for pathogenesis by functioning as both a component in stalled-ribosome rescue and a transcription factor in upregulation of virulence gene expression. Here a specific peptide aptamer PA-1 was selected from pepti...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 8; p. 1766
Main Authors Liu, Peng, Huang, Dongyi, Hu, Xinwen, Tang, Yanqiong, Ma, Xiang, Yan, Rihui, Han, Qian, Guo, Jianchun, Zhang, Yueling, Sun, Qun, Liu, Zhu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.09.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:is an important pathogen of aquatic animals, wherein Small protein B (SmpB) is required for pathogenesis by functioning as both a component in stalled-ribosome rescue and a transcription factor in upregulation of virulence gene expression. Here a specific peptide aptamer PA-1 was selected from peptide aptamer library by bacterial two-hybrid system employing pBT-SmpB as bait. The binding affinity between SmpB and PA-1 was evaluated using enzyme-linked immunosorbent assay. The key amino acids of SmpB that interact with PA-1 were identified. After PA-1 was introduced into , the engineered strain designated as (pN-PA-1) was more sensitive and grew slower under salt stress in comparison with wild type, as the disruption of SmpB by PA-1 resulted in significant transcription reductions of virulence-related genes. Consistent with these observations, (pN-PA-1) was severely attenuated in model organism zebrafish, and vaccination of zebrafish with (pN-PA-1) induced a strong antibody response. The vaccinated zebrafish were well protected against subsequent lethal challenges with virulent parental strain. Collectively, we propose that targeting inhibition of SmpB by peptide aptamer PA-1 possesses the desired qualities for a live attenuated vaccine against pathogenic .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, China
This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
These authors have contributed equally to this work.
Reviewed by: Liang Quanfeng, Shandong University, China; Xiangmin Lin, Fujian Agriculture and Forestry University, China; Chengxian Zhang, Johns Hopkins School of Medicine, United States
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2017.01766